Timothy A. Yap

717 total citations
10 papers, 568 citations indexed

About

Timothy A. Yap is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Timothy A. Yap has authored 10 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Timothy A. Yap's work include Lung Cancer Treatments and Mutations (4 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Research Studies (3 papers). Timothy A. Yap is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Research Studies (3 papers). Timothy A. Yap collaborates with scholars based in United Kingdom, United States and Singapore. Timothy A. Yap's co-authors include Craig P. Carden, Stan B. Kaye, Sanjay Popat, Raghav Sundar, Dearbhaile Catherine Collins, Saoirse Dolly, Murray Yule, John F. Lyons, Matthew Squires and L. Rhoda Molife and has published in prestigious journals such as Journal of Clinical Oncology, Nature reviews. Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Timothy A. Yap

10 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timothy A. Yap United Kingdom	8	289	200	146	111	72	10	568
Shane W. O’Brien United States	12	401 1.4×	188 0.9×	69 0.5×	88 0.8×	44 0.6×	14	602
Jessica C.A. Bouma-ter Steege Netherlands	8	410 1.4×	322 1.6×	198 1.4×	142 1.3×	39 0.5×	9	851
E. Ruth Plummer United Kingdom	13	229 0.8×	210 1.1×	38 0.3×	94 0.8×	20 0.3×	20	470
Michael A. Dengler Germany	14	455 1.6×	109 0.5×	31 0.2×	143 1.3×	59 0.8×	24	706
Takafumi Kuroda Japan	14	439 1.5×	245 1.2×	127 0.9×	172 1.5×	104 1.4×	26	694
Federica Guffanti Italy	13	374 1.3×	300 1.5×	115 0.8×	143 1.3×	73 1.0×	33	577
Juan Cueva Spain	17	256 0.9×	319 1.6×	52 0.4×	234 2.1×	24 0.3×	41	633
Ashwini A. Katre United States	16	802 2.8×	685 3.4×	233 1.6×	350 3.2×	98 1.4×	31	1.3k
Sergey Karakashev United States	10	636 2.2×	270 1.4×	55 0.4×	203 1.8×	59 0.8×	16	778
Tomás Dalotto‐Moreno Argentina	9	661 2.3×	299 1.5×	57 0.4×	106 1.0×	40 0.6×	17	1.1k

Countries citing papers authored by Timothy A. Yap

Since Specialization

Citations

This map shows the geographic impact of Timothy A. Yap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy A. Yap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy A. Yap more than expected).

Fields of papers citing papers by Timothy A. Yap

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy A. Yap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy A. Yap. The network helps show where Timothy A. Yap may publish in the future.

Co-authorship network of co-authors of Timothy A. Yap

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy A. Yap. A scholar is included among the top collaborators of Timothy A. Yap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy A. Yap. Timothy A. Yap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Swanson, David, Melissa P. Mitchell, Wendy A. Woodward, et al.. (2024). Outcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 122(2). 278–291. 1 indexed citations

Dolly, Saoirse, Dearbhaile Catherine Collins, Raghav Sundar, Sanjay Popat, & Timothy A. Yap. (2017). Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer. Drugs. 77(8). 813–827. 41 indexed citations

Sundar, Raghav, Maxime Chénard-Poirier, Dearbhaile Catherine Collins, & Timothy A. Yap. (2017). Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer. Frontiers in Medicine. 4. 39–39. 15 indexed citations

O’Brien, Mary, Merina Ahmed, Sanjay Popat, et al.. (2016). Mechanism and non-mechanism based imaging biomarkers for assessing biological response to treatment in non-small cell lung cancer. European Journal of Cancer. 59. 65–78. 22 indexed citations

Yap, Timothy A., Peter Johnson, Jane N. Winter, et al.. (2016). A phase I, open-label study of GSK2816126, an enhancer of zeste homolog 2 (EZH2) inhibitor, in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), transformed follicular lymphoma (tFL), other non-Hodgkin’s lymphomas (NHL), multiple myeloma (MM) and solid tumor.. Journal of Clinical Oncology. 34(15_suppl). TPS2595–TPS2595. 11 indexed citations

Kumar, Rajiv, Anna Minchom, Adam Sharp, et al.. (2015). A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients. Cancer Chemotherapy and Pharmacology. 77(2). 375–383. 9 indexed citations

Lopez, Juanita, Sam Harris, Desam Roda, & Timothy A. Yap. (2015). Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials. PubMed. Suppl. 1(Suppl 1). 1–11. 8 indexed citations

Yap, Timothy A. & Sanjay Popat. (2013). The role of afatinib in the management of non-small cell lung carcinoma. Expert Opinion on Drug Metabolism & Toxicology. 9(11). 1529–1539. 4 indexed citations

Arkenau, Hendrik‐Tobias, Ruth Plummer, L. Rhoda Molife, et al.. (2011). A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies. Annals of Oncology. 23(5). 1307–1313. 52 indexed citations

10.

Yap, Timothy A., Craig P. Carden, & Stan B. Kaye. (2009). Beyond chemotherapy: targeted therapies in ovarian cancer. Nature reviews. Cancer. 9(3). 167–181. 405 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact